HC Wainwright: A Unique PI3K Inhibitor for Brain Tumors; Initiate With Buy and $17 PT
You can view the full article on Kazia's web site on the home page, under Resouces - 5 January 2021.
IMO, excellent analysis on paxalisib from any of the investment institutions to date.
https://www.kaziatherapeutics.com/
Regards.
- Forums
- ASX - By Stock
- KZA Media Thread
HC Wainwright: A Unique PI3K Inhibitor for Brain Tumors;...
-
- There are more pages in this discussion • 799 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)